Lightning Talk - Ecosystem Considerations in Adopting Large-Volume Onbody Injectors

As the landscape, development, and introduction of large-volume delivery systems continue to grow, the implementation of these devices in the Pharma ecosystem creates unique challenges for pharmaceutical companies. From the selection of drug containment materials and enclosures, to device assembly needs to final packaging, the ecosystem and implementation of these devices must be carefully considered. In this quick discussion we will review some of the ecosystem considerations below.

• Evolving landscape vs uniformity
• Device complexity and options, User Filled, User Assembled, Prefill-Preassembled
• Drug containment choices and second source de-risking
• Post fill device assembly, what complexity does this introduce and do the device companies provide turn key solutions.
• Device packaging and distribution options.
• Lifecyle management especially related to electronics/connected systems
• Sustainability opportunities and disposability